未登录 分享 收藏
分享 收藏
Distinct Immunosuppressive Tumor Microenvironment in Gastric Cancer With Peritoneal Metastasis 胃癌腹膜转移中独特的免疫抑制性肿瘤微环境 Kim, Hongsik; Kwon, Minsuk; Lee, Sun Kyung; Son, Seung-Myoung; Lee, Ok-Jun; Yoon, Soon Man; Kim, Hee Kyung; Yang, Yaewon; Lee, Ki Hyeong; Han, Hye Sook 分享 收藏
分享 收藏
分享 收藏
First-line nivolumab plus platinum chemotherapy and bevacizumab for advanced nonsquamous non-small cell lung cancer: A 3-year follow-up of the phase 3 randomized TASUKI-52 trial 一线纳武利尤单抗联合铂类化疗和贝伐珠单抗治疗晚期非鳞非小细胞肺癌：TASUKI-52 III期随机试验3年随访 Lee, Ki Hyeong; Lee, Jong-Seok; Sugawara, Shunichi; Kang, Jin Hyoung; Kim, Hye Ryun; Inui, Naoki; Hida, Toyoaki; Yoshida, Tatsuya; Tanaka, Hiroshi; Yang, Cheng-Ta; Inoue, Takako; Nishio, Makoto; Ohe, Yuichiro; Tamura, Tomohide; Yamamoto, Nobuyuki; Yu, Chong-Jen; Akamatsu, Hiroaki; Takahashi, Shigeru 分享 收藏
Clinical Outcomes of Maintenance Durvalumab After Definitive Concurrent Chemoradiotherapy in Unresectable Locally Advanced Stage III NSCLC According to EGFR and ALK Status: Korean Cancer Study Group LU-22-18 根据EGFR和ALK状态，不可切除的局部晚期III期NSCLC在确定性同步放化疗后维持Durvalumab的临床结局: 韩国癌症研究小组LU-22-18 Choi, Dae-Ho; Kim, Miso; Kim, Young Saing; Park, Keon Uk; Cho, Jang Ho; Kim, Hongsik; Lee, Ki Hyeong; Ahn, Heejoon; Kim, Il-Hwan; Lee, Kyung-Hee; Lee, Gyeong-Won; Yi, Seong Yoon; Ahn, Beung chul; Lee, Min-Young; Jung, Hyun Ae; Park, Sehhoon; Sun, Jong-Mu; Ahn, Jin Seok; Lee, Se-Hoon; Ahn, Myung-Ju 分享 收藏
分享 收藏
Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer 局限期小细胞肺癌放化疗后的Durvalumab Cheng, Ying; Spigel, David R.; Cho, Byoung Chul; Laktionov, Konstantin K.; Fang, Jian; Chen, Yuanbin; Zenke, Yoshitaka; Lee, Ki Hyeong; Wang, Qiming; Navarro, Alejandro; Bernabe, Reyes; Buchmeier, Eva Lotte; Chang, John Wen-Cheng; Shiraishi, Yoshimasa; Goksu, Sema Sezgin; Badzio, Andrzej; Shi, Anhui; Daniel, Davey B.; Hoa, Nguyen Thi Thai; Zemanova, Milada; Mann, Helen; Gowda, Hema; Jiang, Haiyi; Senan, Suresh 分享 收藏
Updated overall survival and ctDNA analysis in patients with EGFR T790M-positive advanced non-small cell lung cancer treated with lazertinib in the phase 1/2 LASER201 study 1/2期LASER201研究中使用拉泽替尼治疗的EGFR T790M-positive晚期非小细胞肺癌患者的更新的总生存期和ctDNA分析 Han, Ji-Youn; Ahn, Myung-Ju; Lee, Ki Hyeong; Lee, Yun-Gyoo; Kim, Dong-Wan; Min, Young Joo; Kim, Sang-We; Cho, Eun Kyung; Kim, Joo-Hang; Lee, Gyeong-Won; Lee, Sung Sook; Lee, Na Mi; Jang, Hyun Woo; Han, Heewon; Park, Hyejoo; Lee, Jieon; Cho, Byoung Chul 分享 收藏
Efficacy in patients with EGFR-positive non-small-cell lung cancer treated with dacomitinib who had skin adverse events: post hoc analyses from ARCHER 1050 Pu, Xingxiang; Li, Juan; Zhang, Bo; Zhang, Jinyao; Mok, Tony S.; Nakagawa, Kazuhiko; Rosell, Rafael; Cheng, Ying; Zhou, Xiangdong; Miglorino, Maria Rita; Niho, Seiji; Lee, Ki Hyeong; Corral, Jesus; Pluzanski, Adam; Li, Junling; Linke, Rolf; Pan, Fang; Tang, Yiyun; Tan, Weiwei; Wu, Lin 分享 收藏
ABBV-400, a c-Met proteinetargeting antibody-drug conjugate (ADC), in patients (pts) with advanced gastric/gastroesophageal junction adenocarcinoma (GEA): Results from a phase I study ABBV-400，一种靶向c-Met蛋白的抗体偶联药物（ADC），用于晚期胃/胃食管结合部腺癌（GEA）患者（pts）的I期研究结果 Strickler, J. H.; Raimbourg, J.; Ghiringhelli, F.; Cohen, J. E.; Kitagawa, C.; Sharma, M. R.; Lee, K. H.; De Miguel, M.; Hunter, Z. N.; Burns, M.; Li, R. R.; Rudraganguly, N.; de Almeida, C. Biesdorf; Freise, K. J.; Blaney, M. E.; Morrison-Thiele, G.; Aristide, M. R. Neagu; Kuboki, Y. 分享 收藏
Efficacy of ferric carboxymaltose or darbepoetin alfa for chemotherapy-induced anemia in patients with esophagogastric or pancreaticobiliary cancer: a retrospective comparative study Cho, Minkwan; Park, Eunkyung; Lee, Yong-Pyo; Kim, Hongsik; Park, Hee Sue; Kim, Hee Kyung; Yang, Yaewon; Kwon, Jihyun; Lee, Ki Hyeong; Han, Hye Sook 分享 收藏
Novel diagnostic biomarkers for pancreatic cancer: assessing methylation status with epigenetic-specific peptide nucleic acid and KRAS mutation in cell-free DNA Kim, Hongsik; Chu, Jinah; Do, In-Gu; Lee, Yong-Pyo; Kim, Hee Kyung; Yang, Yaewon; Kwon, Jihyun; Lee, Ki Hyeong; Batochir, Chinbayar; Jo, Eunji; Kim, Kyo Rim; Han, Hye Sook 分享 收藏
Phase 1/2 clinical trial of JIN-A02, a 4th generation EGFR-TKI, in patients with 3rd generation EGFR-TKI resistance in EGFR mutated advanced/metastatic non-small cell lung cancer (NSCLC) Lim, Sun Min; Cho, Byoung Chul; Han, Ji Youn; Kim, Sang We; Lee, Ki Hyeong; Nagasaka, Misako; Jo, Anna; Seah, Ethan; Kim, Choonok; Reungwetwattana, Thanyanan 分享 收藏
Amivantamab in wild-type advanced non-small cell lung cancer after disease progression on checkpoint inhibition and chemotherapy: Results from the phase 1b CHRYSALIS study Cho, Byoung Chul; Goldman, Jonathan; Leighl, Natasha; De Braud, Filippo; Lee, Ki Hyeong; Ghiringhelli, Francois; Garrido, Pilar; Peguero, Julio; Besse, Benjamin; Cassier, Philippe; Girard, Nicolas; de Miguel, Maria; Alvarez, Rosa; Greystroke, Alastair; Ohe, Yuichiro; Hsia, Te-Chun; Curtin, Joshua C.; Chowdhury, Sanjib; Lyu, Xuesong; Gao, Grace; Qu, Siyang; Lorenzini, Patricia; Kapoor, Aastha; Kim, Priya; Baig, Mahadi; Thayu, Meena; Knoblauch, Roland E.; Hiret, Sandrine; Tomasini, Pascale 分享 收藏
Summary of Research: Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC 研究总结: 奥希替尼治疗EGFR突变非小细胞肺癌的总生存期 Tsuboi, Masahiro; Herbst, Roy S.; John, Thomas; Kato, Terufumi; Majem, Margarita; Grohe, Christian; Wang, Jie; Goldman, Jonathan W.; Lu, Shun; de Marinis, Filippo; Shepherd, Frances A.; Lee, Ki Hyeong; Le, Nhieu Thi; Dechaphunkul, Arunee; Kowalski, Dariusz; Bonanno, Laura; Domine, Manuel; Poole, Lynne; Bolanos, Ana; Rukazenkov, Yuri; Wu, Yi-Long 分享 收藏
Symptomatic Pneumonitis With Durvalumab After Concurrent Chemoradiotherapy in Unresectable Stage III NSCLC 不可切除的III期NSCLC同步放化疗后Durvalumab的症状性肺炎 Vansteenkiste, Johan F.; Naidoo, Jarushka; Faivre-Finn, Corinne; Ozguroglu, Mustafa; Villegas, Augusto; Daniel, Davey; Murakami, Shuji; Hui, Rina; Lee, Ki Hyeong; Cho, Byoung Chul; Kubota, Kaoru; Broadhurst, Helen; Wadsworth, Catherine; Newton, Michael; Thiyagarajah, Piruntha; Antonia, Scott J. 分享 收藏
Repotrectinib in ROS1 Fusion-Positive Non-Small-Cell Lung Cancer 罗索替尼在ROS1融合阳性非小细胞肺癌中的应用 Drilon, Alexander; Camidge, D. Ross; Lin, Jessica J.; Kim, Sang-We; Solomon, Benjamin J.; Dziadziuszko, Rafal; Besse, Benjamin; Goto, Koichi; de Langen, Adrianus Johannes; Wolf, Juergen; Lee, Ki Hyeong; Popat, Sanjay; Springfeld, Christoph; Nagasaka, Misako; Felip, Enriqueta; Yang, Nong; Velcheti, Vamsidhar; Lu, Shun; Kao, Steven; Dooms, Christophe; Krebs, Matthew G.; Yao, Wenxiu; Beg, Muhammad Shaalan; Hu, Xiufeng; Moro-Sibilot, Denis; Cheema, Parneet; Stopatschinskaja, Shanna; Mehta, Minal; Trone, Denise; Graber, Armin; Sims, Gregory; Yuan, Yong; Cho, Byoung Chul 分享 收藏
Repotrectinib in patients with ROS1 fusion-positive (ROS1+) non-small cell lung cancer (NSCLC): Update from the pivotal phase 1/2 TRIDENT-1 trial Lin, Jessica J.; Cho, Byoung Chul; Camidge, D. Ross; Kim, Sang-We; Solomon, Benjamin; Dziadziuszko, Rafal; Besse, Benjamin; Goto, Koichi; de langen, Adrianus Johannes; Wolf, Jurgen; Lee, Ki Hyeong; Popat, Sanjay; Springfeld, Christoph; Nagasaka, Misako; Felip, Enriqueta; Yang, Nong; Lu, Shun; Kao, Steven; Velcheti, Vamsidhar; Cheema, Parneet; Stopatschinskaja, Shanna; Mehta, Minal; Trone, Denise; Ades, Felipe; Calvet, Christophe Y.; Drilon, Alexander 分享 收藏
.png){kind=icon}
未登录.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
